drugset / Trial / NCT03430817
Citicholine-Amantadine Trial in Traumatic Brain Injury
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized study aims at comparing between the effects of amantadine, citcholine and its combinations on arousal and behavioral consequences in early phase of moderate Traumatic Brain injury (TBI).
Timeline
- Start
- 2017-12-07
- Primary completion
- 2024-03-24
- Completion
- 2024-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amantadine | Unknown | 200 mg | Intravenous |
| Subject | Citicholine | Unknown | 500 mg | Intravenous |
Indications
No indication recorded.